Tepotinib in Patients with MET Exon 14 (METex14) Skipping NSCLC: Primary Analysis of the Confirmatory VISION Cohort C-MedSci.cn

Tepotinib in Patients with MET Exon 14 (METex14) Skipping NSCLC: Primary Analysis of the Confirmatory VISION Cohort C

Thomas, M; Garassino, M; Felip, E; Sakai, H; Le, X; Veillon, R; Smit, E; Mazieres, J; Cortot, A; Raskin, J; Viteri, S; Yang, JCH; Ahn, MJ; Wu, YL; Ma, R; Zhao, J; O'Brate, A; Berghoff, K; Bruns, R; Otto, G; Paik, P

JOURNAL OF THORACIC ONCOLOGY, 2022; 17 (9): S9

科室
- - 订阅+
  - 更多科室
工具
服务